Cancer Center Survivorship Research Forum

---

ONLINE

Friday, July 2, 2021, 12:00 AM - Sunday, December 31, 2023, 11:00 PM, Self-Paced Online

Format: Self-paced online

This course is planned and hosted by Masonic Cancer Center, University of Minnesota. For more information contact [email protected]. 

There are now over 16 million cancer survivors. Many of these survivors go on to have multiple needs and ongoing chronic diseases, higher than the general population. Understanding potential toxicities related to chemotherapy, radiation, immunotherapy, and hormone therapy is essential in providing comprehensive care for all stages of survivorship. During this course you will hear from clinicians and researchers on the ongoing chronic conditions of cancer survivors, areas of research, as well as ways to improve clinical care. This course will address the entire spectrum of cancer survivorship care: monitoring and management of the late and long term effects ranging from cardiotoxicity to cognitive changes, screening for other malignancies, and promotion of healthy lifestyles. The course will also highlight areas of current research and areas in need.

Course Structure This course consists of ten video modules, a completion attestation, and evaluation. The steps to complete the course and receive credit are:

1. Register for the course by clicking on the "register".
2. Login or create a new account for this CE Portal.
3. View each module's video content.
4. Complete the course attestation.
5. Complete the course evaluation and access your Certificate of Participation through My CE in your CE Portal account. Your Certificate of Participation will also be emailed to you. 

Estimated time to complete: 13 hours

Release date: June 28, 2021

Content valid through: December 31, 2023

1. Demonstrate knowledge of treatment-related toxicities for the most common cancers.
2. Discuss gaps in knowledge in cancer survivorship, specifically as it relates to accelerated aging, obesity, and chronic diseases.
3. Develop strategies to further the research and priorities in cancer survivorship.

Registration rate: $30

Registration of this asynchronous course is final with no refunds or transfers. If there are circumstances requiring administrative review, organizers may be contacted directly at [email protected] for a case by case review.

Credit Designation Statements

American Medical Association (AMA)
The University of Minnesota, Interprofessional Continuing Education designates this enduring material for a maximum of 13.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Nurses Credentialing Center (ANCC)
This enduring material is awarded up to 13.0 ANCC contact hours.

Accreditation Council for Pharmacy Education (ACPE)
This enduring material is eligible for up to 13.0 ACPE contact hours. Information from the learner's profile (which includes your NABP # and month and date of birth) will be uploaded to The Monitor within four weeks of your completion of the activity.

Physician Assistants (PAs)
PAs may claim a maximum of 13.0 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.

Other Healthcare Professionals
Other healthcare professionals who participate in this CE activity may submit their statement of participation to their appropriate accrediting organizations or state boards for consideration of credit.

This online course is a recording of the April 15 - 16, 2021 Cancer Survivorship Research Forum. Learners should not claim credit for both the live session and this online course; review your transcript to determine if you received credit for the live session before taking this course. Note the live event received educational grants from Biotheranostics Inc. and Bristol-Myers Squibb. 

The registration form for this activity is currently unavailable.

It is the policy of the University of Minnesota Office of Continuing Professional Development to ensure balance, independence, objectivity and scientific rigor in all of its educational activities. All individuals who have influence over activity content are required to disclose to the learners any financial relationships with an ineligible company (formerly known as a commercial interest). Disclosure information is reviewed in advance in order to mitigate any possible conflicts of interest. Specific disclosure information for each presenter, course director, and planning committee member will be shared with learners prior to the start of the course. Persons who fail to complete the disclosure in advance of the course are not eligible to be involved in this course.

Unless otherwise noted, individuals did not indicate any relevant affiliations or financial interests. Course Director *Anne Blaes, MD Additional Planning Committee Members *Catherine Alfano, PhD *Smita Bhatia, MD, MPH, University of Alabama Catherine Bender, PhD, RN, University of Pittsburgh Jodi Brenden Amir, Accreditation Specialist, University of Minnesota *Jennifer Klemp, PhD, MPH Disclosure: Self, Consultant: AstraZeneca and Pfizer, Inc.; Self, Speaker’s Bureau: Pfizer, Inc.; Self, Grant/Research Support: Myriad Genetic Laboratories, ACCC/Pfizer Grants for Learning and Change; Self, Stock/Shareholder: Cancer Survivorship Training, Inc. Maureen Laschen, MA, University of Minnesota Lissa Martinez Huebner, University of Minnesota *Deborah Mayer, PhD, RN, AOCN, FAAN, University of North Carolina at Chapel Hill Karen Pennington, PA *Lidia Schapira, MD Rowena Schwartz, PharmD *Lucie Trucotte, MD, PhD, University of Minnesota *indicates Planning Committee member also served as Course Faculty

Course Faculty Douglas Yee, MD, University of Minnesota Disclosure: Self, Consultant: Martell Diagnostics; Self, Grant/Research Support: Boehringer Ingleheim Steven Petrow, patient Joanna Heims, BA Susan Dentzer, Senior Policy Fellow Amy Tevaarwerk, MD, University of Wisconsin Eric Wallace, PhD, University of Alabama Linda Jacobs, PhD, CRNP, FAAN, University of Pennsylvania Carissa Low, PhD, University of Pittsburgh Stacey Tinianov, BCPA Helen Parsons, PhD, MPH, University of Minnesota Erin Hahn, PhD, MPH, Kaiser Permanente Tufia Haddad, MD, Mayo Clinic Larissa Nekhlyudov, MD, MPH, Dana-Farber Cancer Institute, Harvard University Rachel I. Vogel, PhD. University of Minnesota Shelley Fuld Nasso, MPP, National Coalition for Cancer Survivorship Shoshana Rosenberg, ScD, MPH, Dana-Farber Cancer Institute, Harvard University Irma M. Verdonck-de Leeuw, PhD, Oncokompass William Wood, MD, MPH, University of North Carolina Disclosure: Self, Consultant: Teladoc; Self, Grant Research: Pfizer; Self, Stock/Shareholder: Koneska Health, Elektra Labs; Self, Honoraria ASH Research Collaborative Shawna Hudson, PhD, Rutgers Tara O. Henderson, MD, MPH, University of Chicago Supriya Mohile, MD, MS, University of Rochester B.R. Simon Rosser, PhD, MPH, LP, University of Minnesota Smita Bhatia, MD, MPH, University of Alabama Jakub Tolar, MD, PhD, University of Minnesota Scott Nelson, patient Emily S. Tonorezos, MD, MPH, National Cancer Institute Ellie Daniels, MD, MPH, American Cancer Society Karim Sadak, MD, MPH, MSE, University of Minnesota Doris Howell, RN, PhD, FAAN (University of Toronto) Patty Spears, Patient Advocate, Alliance) Bogda Koczwara, BM, BS, FRACP, Mbioethics, Flinders University Michelle Mollica, PhD, MPH, RN, OCN, National Cancer Institute Michael Jefford, MBBS, MPH, MHlthServMt, PhD, FRACP, Peter MacCallum Cancer Centre Michael D. Stubblefield, MD, ReVital Cancer Rehabilitation Kevin C. Oeffinger, MD, Duke Cancer Institute Neeraj Arora, PhD, Patient Centered Outcomes Research Center

Mitigation of Relevant Financial Relationships

University of Minnesota Continuing Professional Development adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education and has policies in place to ensure balance, independence, objectivity and scientific rigor in all of its educational activities. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible entities (commercial interests); individuals who fail to complete the disclosure in advance of the course are not eligible to be involved in this course. Specific disclosure information will be shared with learners prior to the start of the course. All relevant conflicts of interest have been mitigated prior to the commencement of the activity.